• Neurologist@mander.xyz
    link
    fedilink
    English
    arrow-up
    0
    ·
    8 days ago

    Completely true. But there would be fewer of them.

    It’s crazy that when my research team comes up with a therapeutic target we believe might lead to curing a disease, we get crickets from drug companies. But when we present therapeutic targets for long term treatment, we get lots of interest.

    • betterdeadthanreddit@lemmy.world
      link
      fedilink
      English
      arrow-up
      0
      ·
      8 days ago

      Could that be (at least partially) explained by those companies looking at a long-term treatment as the more realistic goal after being burned by proposed cures in the past? Lots of quacks out there offer a quick cure, not as many say up front that their product will need a prolonged period of use. Not saying you and yours fit that label but their bullshit tips the signal-to-noise ratio in an unfavorable direction for both relief-seekers and providers.

      I don’t know your field, team’s reputation or the companies you’ve been in contact with though so of course it could be the simple greed motivation too.